Takeaway FDA approval for a GLP-1 drug to treat sleep apnea could come soon, some analysts predict
[DOI] [PubMed] [Google Scholar] 75.Li F, Peng Y, Zhang M, Yang P & Qu S Sleeve gastrectomy activates the GLP-1 pathway in pancreatic cells and promotes GLP-1-expressing cells differentiation in the intestinal tract
Mechanisms of Weight Loss (The Brain and Gut) GLP-1 RAs promote weight loss through a gut-brain axis, acting on receptors in the CNS and gastrointestinal tract to regulate energy balance (Zheng et al., 2024)
Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide : STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide : SUMMIT (risk reduction in HFpEF outcomes